Last reviewed · How we verify
AAVB-039
At a glance
| Generic name | AAVB-039 |
|---|---|
| Sponsor | AAVantgarde Bio Srl |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |